Cancer in aboriginal and Torres Strait Islander people of Australia.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing epidemiological patterns without primary data or systematic search methodology
What was done
This paper reviewed cancer incidence and case survival patterns among Aboriginal and Torres Strait Islander people compared to other Australians based on published epidemiological data.
What was found
The abstract reports no numerical data or effect sizes. Qualitatively, all-site cancer incidence was equivalent to or slightly lower in Aboriginal and Torres Strait Islander Australians than in other Australians. Higher incidence was observed for cancers of the cervix, liver and gallbladder, esophagus, unknown primary site, mouth and throat, lung, and pancreas, while lower incidence was noted for prostate, female breast, colorectal, and melanoma cancers. Case survival was lower in Indigenous populations due to more high-fatality cancers, more advanced stage at diagnosis, comorbidities, and reduced access to complete care.
Why it matters
This summary highlights that cancer survival disparities in Indigenous Australians persist even when overall incidence is comparable, driven by differences in cancer site distribution, stage at presentation, and healthcare access barriers.
Limits
The abstract does not report a sample size, search methodology, inclusion criteria, or specific numerical estimates. As a narrative review, it lacks formal meta-analytic pooling, risk of bias assessments, and subgroup analyses across urban versus remote communities.
Cited by
- partial Indigenous Australians (Aborigines) do not get skin cancer.